» Articles » PMID: 35925142

[ICG Lymph Node Mapping in Cancer Surgery of the Upper Gastrointestinal Tract]

Overview
Specialty General Surgery
Date 2022 Aug 4
PMID 35925142
Authors
Affiliations
Soon will be listed here.
Abstract

The importance of the assessment of the N‑status in gastric carcinoma, tumors of the gastroesophageal junction and esophageal cancer is undisputed; however, there is currently no internationally validated method for lymph node mapping in esophageal and gastric cancer. Near-infrared fluorescence imaging (NIR) is an innovative technique from the field of vibrational spectroscopy, which in combination with the fluorescent dye indocyanine green (ICG) enables intraoperative real-time visualization of anatomical structures. The ICG currently has four fields of application in oncological surgery: intraoperative real-time angiography for visualization of perfusion, lymphography for visualization of lymphatic vessels, visualization of solid tumors, and (sentinel) lymph node mapping. For imaging of the lymph drainage area and therefore the consecutive lymph nodes, peritumoral injection of ICG must be performed. Several studies have demonstrated the feasibility of peritumoral injection of ICG administered 15 min to 3 days preoperatively with subsequent intraoperative visualization of the lymph nodes. So far prospective randomized studies on the validation of the method are still lacking. In contrast, the use of ICG for lymph node mapping and visualization of sentinel lymph nodes in gastric cancer has been performed in large cohorts as well as in prospective randomized settings. Up to now, multicenter studies for ICG-guided lymph node mapping during oncological surgery of the upper gastrointestinal tract are lacking. Artificial intelligence methods can help to evaluate these techniques in an automated manner in the future as well as to support intraoperative decision making and therefore to improve the quality of oncological surgery.

Citing Articles

Postesophagectomy Diaphragmatic Prolapse after Robot-Assisted Minimally Invasive Esophagectomy (RAMIE).

Brunner S, Muller D, Eckhoff J, Lange V, Chon S, Schmidt T J Clin Med. 2023; 12(18).

PMID: 37762986 PMC: 10531742. DOI: 10.3390/jcm12186046.


Laboratory scoring system to predict hepatic indocyanine green clearance ability during fluorescence imaging-guided laparoscopic hepatectomy.

Chen Z, Zeng Q, Shi N, Han H, Chen Z, Zou Y World J Gastrointest Surg. 2023; 15(7):1442-1453.

PMID: 37555108 PMC: 10405101. DOI: 10.4240/wjgs.v15.i7.1442.


The magic mirror: a novel intraoperative monitoring method for parathyroid glands.

Yuan Y, Li X, Bao X, Huangfu M, Zhang H Front Endocrinol (Lausanne). 2023; 14:1160902.

PMID: 37284221 PMC: 10239973. DOI: 10.3389/fendo.2023.1160902.

References
1.
Barbato G, Cammelli F, Braccini G, Staderini F, Cianchi F, Coratti F . Fluorescent lymphography for thoracic duct identification: Initial experience of a simplified and feasible ICG administration. Int J Med Robot. 2022; 18(3):e2380. DOI: 10.1002/rcs.2380. View

2.
Barnes T, MacGregor T, Sgromo B, Maynard N, Gillies R . Near infra-red fluorescence identification of the thoracic duct to prevent chyle leaks during oesophagectomy. Surg Endosc. 2021; 36(7):5319-5325. PMC: 9160097. DOI: 10.1007/s00464-021-08912-1. View

3.
Chakedis J, Shirley L, Terando A, Skoracki R, Phay J . Identification of the Thoracic Duct Using Indocyanine Green During Cervical Lymphadenectomy. Ann Surg Oncol. 2018; 25(12):3711-3717. PMC: 6181776. DOI: 10.1245/s10434-018-6690-4. View

4.
Chen Q, Xie J, Zhong Q, Wang J, Lin J, Lu J . Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial. JAMA Surg. 2020; 155(4):300-311. DOI: 10.1001/jamasurg.2019.6033. View

5.
Chen Q, Zhong Q, Li P, Xie J, Liu Z, Huang X . Comparison of submucosal and subserosal approaches toward optimized indocyanine green tracer-guided laparoscopic lymphadenectomy for patients with gastric cancer (FUGES-019): a randomized controlled trial. BMC Med. 2021; 19(1):276. PMC: 8549272. DOI: 10.1186/s12916-021-02125-y. View